HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.

Abstract
Exercise and work potential of a patient with coexistent myophosphorylase and myoadenylate deaminase (AMPDA) deficiency was compared with that of three patients with myophosphorylase deficiency alone. The patient with the combined defect failed to produce an abnormal rise in serum ammonia or hypoxanthine as seen in the other patients after forearm exercise. Maximum oxygen consumption and work rates during cycle ergometer testing were similar in all patients, but well below controls. The occurrence of two defects involving short-term energy metabolism in muscle presents an opportunity to define further the metabolic role of AMPDA.
AuthorsS L Heller, K K Kaiser, G J Planer, J M Hagberg, M H Brooke
JournalNeurology (Neurology) Vol. 37 Issue 6 Pg. 1039-42 (Jun 1987) ISSN: 0028-3878 [Print] United States
PMID3473311 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hypoxanthines
  • Hypoxanthine
  • Ammonia
  • Nucleotide Deaminases
  • AMP Deaminase
Topics
  • AMP Deaminase (deficiency)
  • Adult
  • Ammonia (blood)
  • Female
  • Glycogen Storage Disease (complications)
  • Glycogen Storage Disease Type V (blood, complications, physiopathology)
  • Humans
  • Hypoxanthine
  • Hypoxanthines (blood)
  • Male
  • Metabolic Diseases (blood, complications, physiopathology)
  • Nucleotide Deaminases (deficiency)
  • Physical Exertion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: